论文部分内容阅读
CAST结果的公布 ,对抗心律失常药物的临床应用提出了挑战。且大多数抗心律失常药物具有不同程度的负性肌力作用更限制了其应用于慢性心力衰竭并心律失常患者。我们选用胺碘酮治疗慢性心力衰竭并频发室性早搏者 ,旨在探讨该药的疗效和安全性 ,现报告如下。1 对象和方法1 1 对
The publication of the CAST results presents a challenge to the clinical application of arrhythmic drugs. And most antiarrhythmic drugs with varying degrees of negative inotropic effect limits their use in patients with chronic heart failure and arrhythmia. We use amiodarone in patients with chronic heart failure and frequent premature ventricular contractions, to explore the efficacy and safety of the drug, are as follows. 1 objects and methods 1 1 pair